Introduction:
HERMES PHARMA, a prominent authority in user-friendly oral dosage forms, is enhancing its manufacturing capabilities to meet growing demand for user-friendly oral dosage form development and production.
Features:
The primary goal is to effectively address the surging market demand for easily consumable oral dosage forms.
Key components of the investment plan include the acquisition of advanced equipment, expansion of production and storage capacities, and operational optimization.
HERMES PHARMA's investment not only serves its own growth objectives but also demonstrates its commitment to helping both new and existing clients achieve their goals.
Traditional tablets and capsules are challenging for approximately 50% of individuals to consume, leading to increased demand for alternatives like orally disintegrating granules (ODGs), chewable tablets, lozenges, instant drinks, and effervescents.
Healthcare companies are actively seeking to incorporate these user-friendly dosage forms into their product portfolios.
Introduction of cutting-edge taste-masking equipment to meet the growing demand for enhanced taste-masking solutions.
Establishment of specialized filling and packaging lines tailored for ODGs and instant drinks to streamline production.
Expansion of the Good Manufacturing Practice (GMP) manufacturing space to accommodate expanding client needs. Development of additional GMP storage capacity to ensure efficient inventory management and on-time deliveries.
Optimization of inventory and goods flow within the shop floor to enhance overall operational efficiency.
HERMES PHARMA's significant investment underscores its leadership position in addressing the evolving needs of the pharmaceutical industry, with a strong focus on delivering user-friendly oral dosage forms to a broader audience.
Specifications:
Name: HERMES PHARMA
Type: Expansion
